Temozolomide Retreatment after Desensitization in Glioma Patients with Temozolomide Hypersensitivity

M. Ruff,J. Uhm, D. Johnson, R. Divekar,D. Maddox

Journal of the neurological sciences（2017）

引用 0|浏览9

暂无评分

摘要

Background: Temozolomide (TMZ) is widely used in the treatment of glioma. TMZ is generally well tolerated, however some patients develop hypersensitivity reactions necessitating discontinuation of therapy.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要